
Anteris
AVR.AXAnteris Technologies Ltd Price (AVR.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
15,605,878
(12.9423)%
Community Sentiment
0 votes
↑ 0%
↓ 0%
Description
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $7.65-23.93
- Market Cap 414.21M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Medical - Devices
- ceo: Mr. Wayne Geoffrey Paterson
- IPO Date: March, 22, 2004
- Country: AU
- Currency: AUD
- Headquaters: Toowong, QLD
- Employees: 136
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
